DDX59 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.700000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.619600E-01
Normal-vs-Stage2
2.841000E-01
Normal-vs-Stage3
1.899580E-01
Normal-vs-Stage4
9.938600E-01
Stage1-vs-Stage2
4.976400E-01
Stage1-vs-Stage3
2.287200E-01
Stage1-vs-Stage4
6.882400E-01
Stage2-vs-Stage3
1.400750E-01
Stage2-vs-Stage4
2.154800E-01
Stage3-vs-Stage4
3.147600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.628600E-01
Normal-vs-AfricanAmerican
7.750000E-01
Normal-vs-Asian
3.458000E-01
Caucasian-vs-AfricanAmerican
3.078600E-01
Caucasian-vs-Asian
5.919400E-01
AfricanAmerican-vs-Asian
2.958000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.931200E-01
Normal-vs-Female
2.653800E-01
Male-vs-Female
8.438600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.664600E-01
Normal-vs-Age(41-60Yrs)
3.401200E-01
Normal-vs-Age(61-80Yrs)
2.598600E-01
Normal-vs-Age(81-100Yrs)
5.039600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.881000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.262200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.053200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.899200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.223400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.822800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.546600E-01
Normal-vs-Daily Drinker
1.474840E-01
Normal-vs-Weekly Drinker
5.349000E-01
Normal-vs-Occasional Drinker
3.814000E-01
Normal-vs-Social Drinker
3.775800E-01
Non Drinker-vs-Daily Drinker
1.803640E-01
Non Drinker-vs-Weekly Drinker
9.673000E-01
Non Drinker-vs-Occasional Drinker
8.410000E-01
Non Drinker-vs-Social Drinker
8.462800E-01
Daily Drinker-vs-Weekly Drinker
3.277800E-01
Daily Drinker-vs-Occasional Drinker
1.465230E-01
Daily Drinker-vs-Social Drinker
1.603840E-01
Weekly Drinker-vs-Occasional Drinker
9.179600E-01
Weekly Drinker-vs-Social Drinker
9.221200E-01
Occasional Drinker-vs-Social Drinker
9.982600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.160000E-02
Normal-vs-Grade 2
1.322310E-02
Normal-vs-Grade 3
5.246500E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.575800E-01
Grade 1-vs-Grade 3
9.550100E-02
Grade 1-vs-Grade 4
8.160000E-02
Grade 2-vs-Grade 3
2.334200E-01
Grade 2-vs-Grade 4
1.322310E-02
Grade 3-vs-Grade 4
5.246500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.487000E-01
Normal-vs-NonDiabetic
1.867610E-01
Diabetic-vs-NonDiabetic
5.773400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.082600E-01
Normal-vs-NoPancreatitis
2.393400E-01
Pancreatitis-vs-NoPancreatitis
2.253200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.635200E-01
Normal-vs-N1
2.746000E-01
N0-vs-N1
4.513400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.038000E-01
Normal-vs-TP53-NonMutant
6.855800E-01
TP53-Mutant-vs-TP53-NonMutant
5.015600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
